{Reference Type}: Journal Article
{Title}: Oral Psoriasis Therapies.
{Author}: James J;Otto T;Gao J;Porter ML;
{Journal}: Dermatol Clin
{Volume}: 42
{Issue}: 3
{Year}: 2024 Jul
{Factor}: 3.645
{DOI}: 10.1016/j.det.2024.02.013
{Abstract}: Oral psoriasis therapies include both older traditional immunosuppressants, such as methotrexate, cyclosporine, and acitretin, as well as newer, more targeted agents, such as apremilast, deucravacitinib, and oral interleukin-23 receptor antagonists. Patients may prefer oral therapies to injectable therapies based on the route of administration. Both older and newer oral psoriasis therapies can be utilized effectively in the treatment of psoriasis. Here, we will review oral agents used in the treatment of psoriasis as well as provide commentary on their role in our current, evolving psoriasis treatment paradigm.